10-Q
XBRL
QUARTERLY REPORT
- Company
- ORAMED PHARMACEUTICALS INC.
- Filed
- May 11, 2023
- Period of Report
- March 31, 2023
- Accession Number
- 0001213900-23-038593
A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →